Enjoy complimentary customisation on priority with our Enterprise License!
The equity management software market size is forecast to increase by USD 547.5 million, at a CAGR of 18.51% between 2023 and 2028. The growth of the market depends on several critical factors. Vendors' pricing strategies, exemplified by IBM's use of volume discounts, tiered pricing, and subscription models, are essential in optimizing IT expenditure and operational efficiency for businesses. Additionally, the expansion of IT infrastructure, including cloud services, AI, and IoT technologies, enables companies to modernize and innovate their operational environments, driving demand for integrated automation solutions. Centralized monitoring capabilities provided by IBM offer real-time visibility into operations, enabling proactive issue resolution and improving overall system performance and security. These factors collectively contribute to a dynamic environment where businesses prioritize efficiency, cost-effectiveness, and technological advancement in their management strategies.
For More Highlights About this Report, Request Free Sample
The market caters to the growing demand for advanced solutions to manage and monitor equity investments in hospitals and healthcare institutions. This software helps in managing various aspects of equity investments, including tracking stock prices, monitoring portfolio performance, and executing trades. The market is driven by the increasing number of surgeries and thrombosis-related conditions, such as Hereditary antithrombin deficiency and AT III deficiency, which require the use of proteins derived from blood clots for treatment. Equity Management Software plays a crucial role in ensuring the effective use of resources and minimizing blood loss during surgeries. It helps in managing tests related to Antithrombin antigen level and activity assays, which are essential for diagnosing and monitoring thrombosis-related conditions.
In addition, the software also facilitates immunological assays for the detection of antibodies against thrombosis-related proteins. The market is expected to grow significantly due to the increasing number of vital organ transplant surgeries and the rising adoption of Extracorporeal membrane oxygenation (ECMO) and Extracorporeal membrane oxidation (ECMO) techniques. The software helps in managing the complex financial transactions involved in these procedures and ensures compliance with regulatory requirements. Overall, Equity Management Software is an essential tool for hospitals and healthcare institutions to optimize their equity investments and improve patient care.
Vendors pricing strategies is notably driving the market growth. In the equity management software market, cross-industry collaborations and ecosystem partnerships are driving innovation and value creation. Vendors are focusing on providing customized solutions to cater to the unique requirements of various industries, including point-of-care testing devices and mobile testing apps for cardiovascular diseases and personalized medicine. To meet the diverse pricing preferences and budgets of customers, software vendors are adopting flexible pricing models. These models are based on the differentiating features and value-added services of the software solutions.
Further, customers consider factors such as return on investment, availability of free models, and limited IT budgets when making purchasing decisions. Consequently, vendors are re-evaluating their software pricing and delivery models to accommodate these economic and market considerations. Thus, such factors are driving the growth of the market during the forecast period.
The rising number of high-net-worth individuals (HNWIs) globally is the key trend in the market. Cross-industry collaborations and ecosystem partnerships have significantly influenced the equity management software market in recent years. With the increasing number of high net worth individuals (HNWIs) worldwide, the demand for advanced equity management solutions has surged. HNWIs, who typically have net worths of over USD 1 million, seek specialized services for managing their substantial investment portfolios. These services include investment in private equity and hedge funds, pre-IPO placements, and pre-ICO sales. To cater to the unique requirements of HNWIs, wealth managers and advisors leverage advanced equity management software. These solutions facilitate efficient portfolio allocation, estate planning, asset protection, and tax management.
Moreover, the advent of point-of-care testing devices and mobile testing apps in healthcare has paved the way for personalized medicine. This trend is expected to further fuel the growth of the equity management software market as HNWIs increasingly invest in the healthcare and life sciences sectors. Thus, such trends will shape the growth of the market during the forecast period.
Increasing availability of open-source solutions is the major challenge that affects the growth of the market. Open-source equity management software has gained significant traction in the business landscape due to its affordability and ease of use. This software caters to the asset management needs of organizations across industries, with small enterprises being the primary adopters. The cost-effective nature of open-source software enables these businesses, which often operate on narrow profit margins, to manage their assets without the need for expensive licensed software. Two notable examples of open-source asset management solutions are Spiceworks by Spiceworks Inc. and SysAid IT Asset Management by SysAid Technologies.
Moreover, cross-industry collaborations and ecosystem partnerships are fostering the growth of this market, with advancements in point-of-care testing devices and mobile testing apps contributing to the integration of personalized medicine into asset management. These developments are expected to expand the scope and utility of open-source equity management software in the healthcare sector and beyond. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
bobsguide - The company offers assest management products for alternative investments, business intelligence, cash management, and compliance.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The start-ups segment is estimated to witness significant growth during the forecast period. Equity management software plays a crucial role in streamlining the workflow and managing all assets centrally for healthcare institutions and clinics. This software is particularly essential in managing hereditary clotting disorders such as hereditary antithrombin deficiency and AT III deficiency. For instance, Acta Haematologica and Frontiers in Neurology have reported on the importance of maintaining optimal antithrombin levels in patients with these conditions to prevent blood clots, thrombosis, and potential death during surgeries and hospital stays. Octapharma, a leading biopharmaceutical company, offers lyophilized antithrombin for the treatment of these conditions.
Get a glance at the market share of various regions Download the PDF Sample
The start-ups segment was the largest and was valued at USD 97.00 million in 2018. Cloud-based equity management software is an ideal platform for healthcare institutions and clinics due to its numerous advantages. These include predictable expenses, no requirement for a powerful local server, no maintenance fees, low IT personnel costs, and free upgrades generally included in the subscription or support fees. This makes it an affordable and efficient solution for managing the financial aspects of healthcare procedures, particularly those related to thromboembolism and antithrombin deficiency. Therefore, the demand for equity management software will increase during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market plays a significant role in the healthcare industry, particularly in managing hereditary clotting disorders such as Hereditary Antithrombin Deficiency and AT III Deficiency. These disorders are characterized by the deficiency of essential proteins, Antithrombin and AT III, which are crucial for preventing blood clots and maintaining blood flow. Acta Haematologica and Frontiers in Neurology are leading scientific journals publishing research on these disorders. The British Heart Foundation and Octapharma are notable organizations actively involved in the research and development of therapeutics for these conditions. For instance, Octapharma offers Atenativ, a lyophilized antithrombin derived from goat milk, for the treatment of hereditary antithrombin insufficiency. Thrombosis, a potential complication of these disorders, can lead to blood loss during surgeries and even death. Rapid tests and activity assays are essential for monitoring antithrombin deficiency and antithrombin antigen levels.
In addition, immunological assays are used to measure the activity of these proteins. Extracorporeal membrane oxidation (ECMO) is a vital healthcare procedure used in treating severe thrombosis and sepsis-induced coagulopathy. Drugs like heparin and recombinant antithrombin are commonly used to manage thrombosis and prevent blood clotting. The therapeutic segment of the Equity Management Software Market focuses on developing and commercializing these drugs. Genetic disorders, such as mutations in the SERPINC1 gene, can also lead to antithrombin deficiency. In conclusion, the Equity Management Software Market plays a crucial role in managing hereditary clotting disorders by facilitating the development, production, and commercialization of essential therapeutics. These include drugs like Atenativ and heparin, as well as diagnostic tests and healthcare procedures like ECMO. Effective management of these disorders is crucial for preventing complications like thrombosis and ensuring the safety of patients undergoing surgeries.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
You may also interested in below market reports:
The healthcare industry is witnessing significant advancements in the diagnosis and treatment of various clotting disorders, including antithrombin deficiency. Acta Haematologica and the British Heart Foundation are among the leading research organizations focusing on this condition. Companies like Octapharma and Atenativ are developing innovative solutions to address antithrombin deficiencies caused by the SERPINC1 gene mutation. Antithrombin is a vital protein that plays a crucial role in preventing blood clots. Deficiencies in antithrombin can lead to severe complications such as thrombosis, blood loss, and even death during surgeries. Rapid tests and activity assays are essential for diagnosing antithrombin deficiency, while immunological assays help determine antithrombin antigen levels. Equity management software plays a crucial role in the healthcare industry by facilitating the efficient management of drugs, tests, and healthcare procedures related to antithrombin deficiency and blood clotting disorders. Additionally, the therapeutic segment of this software market includes drugs used for treating thromboembolism, such as lyophilized antithrombin derived from goat milk.
Moreover, extracorporeal membrane oxygenation (ECMO) is a vital procedure used to treat severe cases of sepsis shock and hereditary antithrombin insufficiency. Equity management software helps streamline the process of managing ECMO treatments, ensuring optimal patient care and reducing the risk of complications. In conclusion, the market in the healthcare industry is poised for growth due to the increasing demand for efficient management of drugs, tests, and healthcare procedures related to antithrombin deficiency and blood clotting disorders. The market is expected to witness significant growth in the coming years as more research is conducted to develop effective treatments for these conditions. The market is vital for ensuring efficient management of diverse aspects like low molecular weight heparin administration and blood clot prevention, crucial post surgery. It plays a pivotal role in safeguarding vital organs by addressing conditions like septic shock and managing clotting disorders and protein deficiencies. Advanced features include rapid test capabilities and adherence to guidelines from the American Society of Hematology, supporting critical scenarios such as heart surgery and the diagnosis of antithrombin deficiency in clinical settings.
Market Scope |
|
Report Coverage |
Details |
Page number |
152 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 18.51% |
Market growth 2024-2028 |
USD 547.5 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
15.88 |
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
Performing market contribution |
North America at 40% |
Key countries |
US, UK, China, India, and Germany |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Altvia Solutions LLC, bobsguide, By Global Shares, Capdesk, Computershare Ltd., Diligent Corp., Dynamo Software Inc., Equiniti Group, Eqvista Inc., eShares Inc. DBA Carta Inc., Euronext N.V., GS Topco GP LLC, Gust Inc., HighCastle, Imagineer Technology Group LLC, Ledgy AG, Papaya Global Ltd., Prolific Labs Inc., Qapita Corp., and Vestd Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.